You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

1530 Results
Document
Nov 2017
Document
Nov 2017
Document
Nov 2017
Document
Nov 2017
Document
Nov 2017
Document
Nov 2017
Document
Nov 2017
Regimen
Cancer Type:
Gastrointestinal, 
Esophagus, 
Gastric / Stomach
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant
Funding:
ODB - General Benefit
    capecitabine
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
CISplatin,
capecitabine
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Apr 2023
Document
Nov 2017
Document
Nov 2017
Guidelines and Advice
Status: Current
ID: GL-C50-19
Jan 2015
Document
Nov 2017

Pages